FMC Receives Injunction for Chlorantraniliprole: Coverage-Disclosure, Anticipation, and Issues That Remained Unaddressed
SpicyIP
AUGUST 15, 2021
Anticipation by Prior Publication and Lack of Novelty. The defendant argued that CTPR was disclosed and published in US’424, US’357 and EP’508 patents which are Markush type patents and have priority dates even prior to IN’978. Things to Look Out for at the Trial.
52 
Let's personalize your content